Glutamine synthetase-induced enhancement of β-amyloid peptide aβ(1-40) neurotoxicity accompanied by abrogation of fibril formation and Aβ fragmentation

Journal of Neurochemistry

Volumn 66, Issue 5, 1996, Pages 2050-2056

  Aksenov, M Y ^a   Aksenova, M V ^a   Butterfield, D A ^a   Hensley, K ^a   Vigo Pelfrey, C ^b   Carney, J M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Athena Neurosciences Inc   (United States)

Author keywords

Amyloid; Fibrils; Glutamine synthetase; Peptide fragmentation

Indexed keywords

AMYLOID BETA PROTEIN; GLUTAMATE AMMONIA LIGASE;

ALZHEIMER DISEASE; ARTICLE; ENZYME INACTIVATION; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SENILE PLAQUE;

EID: 0029969354     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66052050.x     Document Type: Article

References (55)

1. Aksenov M. Y., Aksenova M. V., Harris M. E., Hensley K., Butterfield D. A., and Carney J. M. (1995) Enhancement of β-amyloid peptide Aβ(1-40)-mediated neurotoxicity by glutamine synthetase. J. Neurochem. 65, 1899-1902.
2. Arispe N., Polland H. B., and Rojas E. (1993) Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [AβP-(1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. USA 90, 10573-10577.
3. Balazs L. and Leon M. (1994) Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem. Res. 19, 1131-1137.
4. Behl C., Davis J., Cole G., and Schubert D. (1992) Vitamin E protects nerve cells from β protein toxicity. Biochem. Biophys. Res. Commun. 186, 944-950.
5. Behl C., Davis J. B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
6. Bigl M. and Eschrich K. (1995) Interaction of rat brain phosphofructokinase with Alzheimer's beta A4-amyloid. Neurochem. Int. 26, 69-75.
7. Buee L., Ding W., Anderson J. P., Narindresorasak S., Kisilevsky R., Boyle N. J., Robakis N. K., Delacourte A., Greenberg B., and Fillit H. M. (1993) Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Res. 627, 199-204.
8. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C., and Glabe C. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267, 546-554.
9. Busciglio J., Lorenzo A., and Yankner B. A. (1992) Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging 13, 609-612.
10. Busciglio J., Yeh J., and Yankner B. A. (1993) β-Amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J. Neurochem. 61, 1565-1568.
11. Butterfield D. A., Hensley K., Harris M., Mattson M., and Carney J. M. (1994) β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200, 710-715.
12. 2+, nitroxide spin probes, and synaptosomal membrane proteins. Life Sci. 58, 217-228.
13. Castaño E. M., Prelli F., Wisniewski T., Golabek A., Kumar R. A., and Frangione B. (1995) Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E. Biochem. J. 306, 599-604.
14. Chauhan A., Chauhan V. P., Murakami N., Brockerhoff H., and Wisniewski H. M. (1993) Amyloid β-protein stimulates casein kinase I and casein kinase II activities. Brain Res. 629, 47-52.
15. Chen L., Richardson J. S., Caldwell J. E., and Ang L. C. (1994) Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer's disease and from nondemented controls. Int. J. Neurosci. 75, 83-90.
16. Cotman C. W., Pike C. J., and Copani A. (1992) β-Amyloid neurotoxicity: a discussion of in vitro findings. Neurobiol. Aging 13, 587-590.
17. Dyrks T , Dyrks E., Hartmann T., Masters C., and Beyreuther K. (1992) Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267, 18210-18217
18. Einstein G., Buranosky R , and Crain B. J. (1994) Dendritic pathology of granule cells in Alzheimer's disease is unrelated to neuritic plaques. J. Neurosci. 14, 5077-5088.
19. Eriksson S , Janciauskiene S., and Lannfelt L. (1995) Alpha 1-antichymotrypsin regulates beta-amyloid peptide fibril formation. Proc. Natl. Acad. Sci. USA 92, 2313-2317.
20. + channels. Science 264, 276-279.
21. Frautschy S. A., Baird A., and Cole G. M. (1991) Effects of injected Alzheimer β-amyloid cores in rat brain. Proc. Natl. Acad. Sci. USA 88, 8362-8366.
22. Golabek A., Marques M. A., Lalowski M., and Wisniewski T. (1995) Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid Neurosci. Lett. 191, 79-82.
23. Good T. A. and Murphy R. M. (1995) Aggregation state-dependent binding of β-amyloid peptide to protein and lipid components of rat cortical homogenates. Biochem. Biophys. Res. Commun. 207, 209-216
24. Goodman Y. and Mattson M. P. (1994) Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide toxicity and oxidative injury. Exp. Neurol. 128, 175-182.
25. Harris M. E., Hensley K., Butterfield D. A., Leedle R. A., and Carney J. M. (1995) Direct evidence of oxidative injury produced by the Alzheimer's amyloid beta-peptide (1-40) in cultured hippocampal neurons. Exp. Neurol. 131, 193-202.
26. Hensley K., Carney J. M., Mattson M. P., Aksenova M. V., Harris M. E., Wu J. F., Floyd R. A., and Butterfield D. A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 3270-3274.
27. Hensley K., Aksenova M., Carney J. M., Harris M., and Butterfield D. A. (1995a) Amyloid β-peptide spin trapping I: peptide enzyme toxicity is related to free radical spin trap reactivity. Neuroreport 6, 489-492.
28. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita P., Wu J. F., Carney J. M., Lowell M., Markesbery W. R., and Butterfield D. A. (1995b) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
29. Ikura K., Takahata K., and Sasaki R. (1993) Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer β/A4 amyloid protein by transglutaminase. FEBS Lett. 326, 109-111.
30. Jiang H., Burdick D., Glabe C. G., Cotman C. W., and Tenner A. J. (1994) β-Amyloid activates complement by binding to a specific region of the collagen-like domain of the Clq A chain. J. Immunol. 152, 5050-5059.
31. Kowall N. W., Beal M. F., Busciglio J., Duffy L. K., and Yankner B. (1991) An in vivo model for the neurodegenerative effects of β-amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA 88, 7247-7251.
32. Lorenzo A. and Yankner B. A. (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl Acad. Sci. USA 91, 12243-12247.
33. Mark R., Hensley K., Butterfield D. A., and Mattson M. P. (1995) Amyloid β-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca-homeostasis and cell death. J. Neurosci. 15, 6239-6249.
34. Markesbery W. R., Lovell M. A., and Ehmann W. D. (1994) Increased lipid peroxidation and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurobiol. Aging 15 (Suppl.), S139-S140.
35. Matsubara E., Frangione B., and Ghiso J. (1995) Characterization of apolipoprotein J-Alzheimer Aβ interaction. J. Biol. Chem. 270, 7563-7567.
36. Mattson M. P. and Goodman Y. (1995) Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res. 676, 219-224.
37. Oda T., Wals P., Osterbung H., Johnson S., Pasinetti G., Morgan T., Rozovsky I., Stine W. B., Snyder S., Holzman T., Krafft G., and Finch C. (1995) Clusterin (apoJ) alters the aggregation of amyloid β-peptide (Aβ 1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress. Exp. Neurol. 136, 22-31.
38. Pike C. J., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1991) Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207, 367-368.
39. Pike C. J., Cummings B. J., and Cotman C. W. (1992) β-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. Neuroreport 3, 769-772.
40. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
41. Pike C. J., Walencewicz-Wasserman A. J., Kosmoski J., Cribbs D. H., Glabe C. G., and Cotman C. W. (1995) Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64, 253-265.
42. Pollack S. J., Sadler I. I., Hawtin S. R., Tailor V. J., and Shearman M. S. (1995) Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells. Brain Res. 671, 282-292.
43. Roher A. E., Kasunic T. C., Woods A. S., Cotter R. J., Ball M. J., and Fridman R. (1994) Proteolysis of Aβ peptide from Alzheimer disease brain by gelatinase A. Biochem. Biophys. Res. Commun. 205, 1755-1761.
44. Sabo S., Lambert M. P., Kessey K., Wade W., Krafft G., and Klein W. L. (1995) Interaction of beta-amyloid peptides with integrins in a human nerve cell line. Neurosci. Lett. 184, 25-28.
45. Schägger H. and Von Jagow G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166, 368-379.
46. Schubert D., Behl C., Lesley R., Brack A., Dargusch R., Sagara Y., and Kimura H. (1995) Amyloid peptides are toxic via common oxidative mechanism. Proc. Natl. Acad. Sci. USA 92, 1989-1993.
47. Schultz J., Schaller J., McKinley M., Bradt B., Cooper N., May P., and Rogers J. (1994) Enhanced cytotoxicity of amyloid beta-peptide by a complement dependent mechanism. Neurosci. Lett. 175, 99-102.
48. Selkoe D. L. (1994) Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 17, 489-517.
49. Simmons L. K., May P. C., Tomaselli K. J., Rydel R. E., Fuson K. S., Brigham E. F., Wright S., Lieberburg I., Becker G. W., Brems D. N., and Li W. Y. (1994) Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45, 373-379.
50. Tomiyama T., Asano S., Suwa Y., Morita T., Kataoka K., Mori H., and Endo N. (1994) Rifampicin prevents the aggregation and neurotoxicity of amyloid β protein in vitro. Biochem. Biophys. Res. Commun. 204, 76-83.
51. Whitson J. S., Mims M. P., Strittmatter W. J., Yamaki T., Morrisett J. D., and Appel S. H. (1994) Attenuation of the neurotoxic effect of Aβ peptide by apolipoprotein E. Biochem. Biophys. Res Commun. 199, 163-170.
52. Wisniewski T., Golabek A., Matsubara E., Ghiso J., and Frangione B. (1993) Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochem. Biophys. Res. Commun. 192, 359-365.
53. Wisniewski T., Castaño E. M., Golabek A., Vogel T., and Frangione B. (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145, 1030-1035.
54. Yankner B. A. (1992) Commentary and perspective on studies of beta amyloid neurotoxicity. Neurobiol. Aging 13, 615-616.
55. Zhao X., Valantas J. A., Vyas S., and Duffy L. K. (1993) Comparative toxicity of amyloid beta-peptide in neuroblastoma cell lines: effects of albumin and physalaemin. Comp. Biochem. Physiol. 106, 165-170.